TP53 and neoplasm: Tumour formation is associated with loss-of-heterozygosity events that delete the functional copy (Mahdavi et al., 2019) and is accelerated by concomitant inactivation of the TP53 (or p53) tumour suppressor protein (Kim et al., 2016; Liu et al., 2007; Zhu et al., 2022).